Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'


Hokkaido University \| Library \| HUSCAP	Advanced Search		言語

	Home
	About HUSCAP
	Open Access Policy

	Browse by Author

Browse
	Communities & Collections

	Scholarly Journals
	Theses
	Doctoral Dissertations Listed by Graduate Schools
	Conference Procs.
	Events

	HUSCAP Senior (in Japanese)

	Societies

	Downloads (country)

For university staff
	How to post your papers to HUSCAP
	Publication of theses
	Helpline about theses publication

Open Archives Compliant

You can search our collection also at:
	Google
	Google Scholar
	CiNii
	IRDB
	OAIster
	NDLTD

Files in This Item:

bjc201758.pdf

125.03 kB

PDF

Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/68542

Title:	Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'
Authors:	Imafuku, Keisuke Browse this author
	Yoshino, Koji Browse this author
	Yamaguchi, Kei Browse this author
	Tsuboi, Satoshi Browse this author
	Ohara, Kuniaki Browse this author
	Hata, Hiroo Browse this author →KAKEN DB
Issue Date:	11-Apr-2017
Publisher:	Nature Publishing Group
Journal Title:	British Journal of Cancer
Volume:	116
Issue:	8
Start Page:	e14
Publisher DOI:	10.1038/bjc.2017.58
PMID:	28324884
Rights:	http://creativecommons.org/licenses/by-nc-sa/4.0/
Type:	article
URI:	http://hdl.handle.net/2115/68542
Appears in Collections:	医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 秦洋郎

OAI-PMH ( junii2 , jpcoar_1.0 )

- Hokkaido University